Contact this trialFirst, we need to learn more about you.
Anti-cancer agent
Eflornithine + Temozolomide for Glioblastoma
Recruiting1 awardPhase 1
Durham, North Carolina
This trial tests a new drug combo to treat newly-diagnosed glioblastoma to see if it's safe & effective.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.